An analysis of China's national essential medicines policy

被引：0
|
作者：
Xiaodong Guan
Huigang Liang
Yajiong Xue
Luwen Shi
机构：
[1] Peking University,Department of Pharmacy Administration and Clinical Pharmacy
[2] Center for Health Management Systems,undefined
[3] College of Business,undefined
[4] East Carolina University,undefined
[5] International Research Center of Medicinal Administration,undefined
[6] Peking University,undefined
来源：
Journal of Public Health Policy | 2011年 / 32卷
关键词：
essential medicines; China; pharmaceutical policy; health-care reform;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Although China embraced the concept of essential medicines in 1979 and issued its first National Essential Medicines List in 1982, until recently China has lacked a comprehensive national essential drug policy. In its most recent health-care reform (2009–2012), the Chinese government explicitly proposed the establishment of a national essential medicines system, and made it one of five top priorities in the coming years. We review the evolution of China's essential medicines policies, explain the importance of fully implementing the essential medicines policy, and analyze recent policy developments surrounding essential medicines.
引用
收藏
页码：305 / 319
页数：14
相关论文
共 50 条
  • [21] Selection of essential medicines for South Africa - an analysis of in-depth interviews with national essential medicines list committee members
    Velisha Ann Perumal-Pillay
    Fatima Suleman
    BMC Health Services Research, 17
  • [22] Selection of essential medicines for South Africa - an analysis of in-depth interviews with national essential medicines list committee members
    Perumal-Pillay, Velisha Ann
    Suleman, Fatima
    BMC HEALTH SERVICES RESEARCH, 2017, 17
  • [23] Access to essential medicines in national constitutions
    Perehudoff, S. K.
    Laing, R. O.
    Hogerzeil, H. V.
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2010, 88 (11) : 800 - 800
  • [24] Impact of price deregulation policy on the affordability of essential medicines for women's health: a panel data analysis
    Liu, Junjie
    Wang, Liming
    Liu, Chenxi
    Zhang, Xinping
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2017, 17 (06) : 625 - 631
  • [25] Analysis of the price difference rate between essential and non-essential medicines in China
    Cai, Xinzhao
    Cui, Zhi
    Liu, Zhiting
    Bian, Ying
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 302 - 303
  • [26] Patient satisfaction with prescribed medicines in community health services in China: A cross-sectional survey 6years after the implementation of the national essential medicines policy
    Ren, Jianping
    Huang, Xianhong
    Zhang, Tao
    Zhou, Xueyang
    Liu, Chaojie
    Wang, Xiaodi
    HEALTH & SOCIAL CARE IN THE COMMUNITY, 2018, 26 (04) : 495 - 506
  • [27] Evaluating the accessibility of essential medicines in China
    Xi, Xiaoyu
    Chen, Piaopiao
    Yang, Fan
    Yang, Yifan
    Chen, Lili
    Mao, Ningying
    JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (08) : 784 - 792
  • [28] Evaluating Australia's National Medicines Policy using geographical mapping
    Roughead, EE
    Monteith, GR
    Harvey, KJ
    Tett, SE
    INTERNAL MEDICINE JOURNAL, 2002, 32 (03) : 66 - 71
  • [29] The effect of essential medicines programme on rational use of medicines in China
    Gong, Yanhong
    Yang, Chen
    Yin, Xiaoxv
    Zhu, Minmin
    Yang, Huajie
    Wang, Yunxia
    Li, Yongbin
    Liu, Liqun
    Dong, Xiaoxin
    Cao, Shiyi
    Lu, Zuxun
    HEALTH POLICY AND PLANNING, 2016, 31 (01) : 21 - 27
  • [30] WHO ON ESSENTIAL MEDICINES On WHO's essential medicines process and transparency
    Magrini, Nicola
    Robertson, Jane
    de Joncheere, Kees
    Bero, Lisa
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
12345